Stone, M., Eriksen, E. F., Lyles, K. W., Colon-Emeric, C. S., Pieper, C. F., Magaziner, J. S., … McLellan, A. (2008). Timing of first infusion of zoledronic acid 5 mg after recent hip fracture affects antifracture efficacy and reduction of mortality. CALCIFIED TISSUE INTERNATIONAL, 83(1), 8–8.

Stone, M., E. F. Eriksen, K. W. Lyles, C. S. Colon-Emeric, C. F. Pieper, J. S. Magaziner, J. D. Adachi, et al. “Timing of first infusion of zoledronic acid 5 mg after recent hip fracture affects antifracture efficacy and reduction of mortality.” CALCIFIED TISSUE INTERNATIONAL 83, no. 1 (July 1, 2008): 8–8.

Stone M, Eriksen EF, Lyles KW, Colon-Emeric CS, Pieper CF, Magaziner JS, et al. Timing of first infusion of zoledronic acid 5 mg after recent hip fracture affects antifracture efficacy and reduction of mortality. CALCIFIED TISSUE INTERNATIONAL. 2008 Jul 1;83(1):8–8.

Stone, M., et al. “Timing of first infusion of zoledronic acid 5 mg after recent hip fracture affects antifracture efficacy and reduction of mortality.” CALCIFIED TISSUE INTERNATIONAL, vol. 83, no. 1, SPRINGER, July 2008, pp. 8–8.

Stone M, Eriksen EF, Lyles KW, Colon-Emeric CS, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Nordsletten L, Boonen S, Mesenbrink P, Reid DM, Wass J, Dennison E, Summers GD, McLellan A. Timing of first infusion of zoledronic acid 5 mg after recent hip fracture affects antifracture efficacy and reduction of mortality. CALCIFIED TISSUE INTERNATIONAL. SPRINGER; 2008 Jul 1;83(1):8–8.